Anti-tumor therapy
US9790504B2 · kind B2 · utility
8Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 21, 2014 |
| Grant date | Oct 17, 2017 |
| Priority date | — |
| Expiry date | May 21, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Panels, compositions, and methods for treating cancer in a subject in need thereof are disclosed involving one or more genes the suppression of which renders the cancer chemosensitive and/or radiosensitive.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.